Cerevel Therapeutics Holdings News

Cerevel Therapeutics Hldg Analyst Ratings

BenzingaFeb 16 18:46 ET

Mizuho Raises Price Target on Cerevel Therapeutics to $45 From $25 to Reflect Sale Price to AbbVie, Keeps Neutral Rating

MT NewswiresFeb 15 08:13 ET

JP Morgan Maintains Neutral on Cerevel Therapeutics Hldg, Raises Price Target to $45

BenzingaDec 28, 2023 05:52 ET

Cerevel Therapeutics Hldg Analyst Ratings

BenzingaDec 28, 2023 05:48 ET

Cerevel Therapeutics Hldg Analyst Ratings

BenzingaDec 22, 2023 05:22 ET

AbbVie Upgraded at Goldman Sachs on Improving Outlook

Seeking AlphaDec 11, 2023 11:14 ET

Analysts Offer Insights on Healthcare Companies: Cooper Co (COO), R1 RCM (RCM) and Cerevel Therapeutics Holdings (CERE)

TipRanksDec 11, 2023 02:10 ET

HC Wainwright Downgrades Cerevel Therapeutics to Neutral From Buy, Raises Price Target to $45 From $41

MT NewswiresDec 7, 2023 12:18 ET

Cantor Fitzgerald Downgrades Cerevel Therapeutics Hldg to Neutral, Raises Price Target to $45

BenzingaDec 7, 2023 05:50 ET

Cerevel Therapeutics Hldg Analyst Ratings

BenzingaDec 7, 2023 05:48 ET

JP Morgan Reinstates Neutral on Cerevel Therapeutics Hldg, Announces $25 Price Target

BenzingaNov 20, 2023 07:44 ET

Cerevel Therapeutics Hldg Analyst Ratings

BenzingaNov 20, 2023 07:39 ET

Analysts Offer Insights on Healthcare Companies: Cerevel Therapeutics Holdings (CERE), Genmab (GMAB) and BioMarin Pharmaceutical (BMRN)

TipRanksNov 6, 2023 02:01 ET

Analysts Offer Insights on Healthcare Companies: TG Therapeutics (TGTX), Aurinia Pharmaceuticals (AUPH) and Cerevel Therapeutics Holdings (CERE)

TipRanksNov 2, 2023 14:00 ET

Morgan Stanley Maintains Overweight on Cerevel Therapeutics Hldg, Lowers Price Target to $38

BenzingaNov 2, 2023 12:11 ET

Cerevel Therapeutics Hldg Analyst Ratings

BenzingaNov 2, 2023 12:10 ET

Analysts' Opinions Are Mixed on These Healthcare Stocks: Cerevel Therapeutics Holdings (CERE) and TG Therapeutics (TGTX)

TipRanksNov 1, 2023 14:50 ET

Cerevel Therapeutics Hldg Analyst Ratings

BenzingaSep 28, 2023 05:23 ET

Cerevel Therapeutics Hldg Analyst Ratings

BenzingaAug 7, 2023 07:44 ET

Cerevel Therapeutics Holdings (CERE) Gets a Hold From Mizuho Securities

TipRanksAug 7, 2023 06:25 ET